Virbac Patents – Key Insights and Stats

Virbac has a total of 664 patents globally, out of which 377 have been granted. Of these 664 patents, more than 42% patents are active. The United States of America is where Virbac has filed the maximum number of patents, followed by Europe and Australia. Parallelly, France seems to be the main focused R&D centre and also is the origin country of Virbac.

Virbac was founded in the year 1968. Healthcare services are offered by Virbac. The business produces vaccines, worm treatments, and antibiotics for veterinary usage. As of April 2023, the market cap of Virbac is $2.6 Billion.

Do read about some of the most popular patents of Virbac which have been covered by us in this article and also you can find Virbac patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Virbac patent portfolio.

How many patents does the founder and the CEO of Virbac have?

The founder Pierre-Richard Dick have 2 patents and CEO Sebastien Huron have 10 patents.

How many patents does Virbac have?

Virbac has a total of 664 patents globally. These patents belong to 207 unique patent families. Out of 664 patents, 282 patents are active.

How Many Patents did Virbac File Every Year?

Virbac Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantVirbac Applications FiledVirbac Patents Granted
20232
202237
2021220
2020325
20191234
20181125
20171125
2016615
2015921
20141412
20131111
2012726
20111115

How many Virbac patents are Alive/Dead?

Virbac Patent Portfolio

How Many Patents did Virbac File in Different Countries?

Virbac Worldwide Patent Filing

Countries in which Virbac Filed Patents

CountryPatent
United States Of America85
Europe82
Australia53
France51
Germany48
Brazil31
Spain29
New Zealand24
China24
Japan22
India17
Canada16
South Africa15
Mexico15
Austria14
United Kingdom8
Denmark7
Chile7
Colombia6
Slovenia5
Portugal4
Italy4
Norway4
Argentina3
Taiwan2
Morocco2
Hong Kong (S.A.R.)2
Africa2
Ecuador1
Uruguay1
Tunisia1
Panama1

Where are Research Centres of Virbac Patents Located?

R&D Centres of Virbac

10 Best Virbac Patents

EP1331222A1 is the most popular patent in the Virbac portfolio. It has received 44 citations so far from companies like Basf, Makhteshim Chemical Works and Shanghai Tahoe Chemical.

Below is the list of 10 most cited patents of Virbac:

Publication NumberCitation Count
EP1331222A144
US6337318B142
WO2005123120A142
WO2003022242A141
US6500446B138
US6653288B134
WO2003002102A129
US20040234572A122
US6913761B118
US7396820B217

How many inventions of other companies were rejected due to Virbac patents?

The statistics below share strategic R&D insights. It tells the companies that were trying to protect inventions similar to Virbac invention. They couldn’t because Virbac had protected those before them.

Examiners at the USPTO referred 17 Virbac patents in 59 rejections (35 USC § 102 or 35 USC § 103 types).

The top citing companies in the Virbac patent portfolio are Wenzhou Yuxiang Pet Product, Medtronic and The Broad Institute.

List of the Companies whose Patents were rejected citing Virbac –

CompanyNumber of Patent Applications that faced Rejection Citing Virbac PatentsNumber of Rejections (102 & 103)
Wenzhou Yuxiang Pet Product36
Medtronic36
The Broad Institute12
Miv Therapeutics11
Warsaw Orthopedic12
Biowish Technologies11
Pola Pharma11
Blueberry Therapeutics11
University Of Texas System14
Chesapeake Therapeutics11

Count of 102 and 103 Type Rejections based on Virbac Patents

Top Virbac Patents used in Rejecting Most Patent Applications

Patent NumberCount of Rejected Applications
US20050063907A15
US9681642B23
US9259448B23
US20080200427A12
US6500446B12
US20060068039A11
US20150335620A11
US20040247634A11
US6337318B11
US8197839B21
US9974736B21
US9260231B21
US20030124567A11
US9750797B21
US6890955B21

What Percentage of Virbac US Patent Applications were Granted?

Virbac (Excluding its subsidiaries) has filed 11 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 6 have been granted leading to a grant rate of 54.55%.

Below are the key stats of Virbac patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Virbac?

Law FirmTotal ApplicationsSuccess Rate
Nicolas E Seckel580.00%
Whda Llp30.00%
Alston & Bird1100.00%
Morgan Lewis & Bockius10.00%
Volpe Koenig1100.00%

What are Virbac key innovation segments?

What Technologies are Covered by Virbac?

The chart below distributes patents filed by Virbac in different countries on the basis of the technology protected in patents. It also represents the markets where Virbac thinks it’s important to protect particular technology inventions.

R&D Focus: How has Virbac search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Virbac Patents?

Related Articles

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.